Blog
BeCytes Biotechnologies
New nomenclature for liver disease (NASH and NAFLD vs MASH and MASLD) The liver diseases nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) have changed names by a [...]
Published On: 06/12/2023
Tips to work with primary hepatocytes Following proper primary liver cell culture handling guidelines is essential to grant success in your in vitro experiments. To obtain the best results, [...]
Published On: 22/11/2023
Suspension vs. plateable hepatocytes, the importance of timing Choices never end. Once we decide to use primary hepatocytes over immortalized cell lines, should we use suspension or plateable primary [...]
Published On: 13/11/2023-
Why should you be using primary hepatocytes? Choosing the right in vitro model for biomedical research may seem overwhelming, especially when many options are available. Primary human hepatocytes and [...]
Published On: 26/10/2023 -
Non-Parenchymal Cells: The Significant 30% The liver is a complex organ comprising hepatocytes, which represent approximately 70% of its total cell population. What about the other 30%? Non-parenchymal cells [...]
Published On: 16/10/2023 
What tissue format are available for your experiments? When it comes to conducting experiments in biomedical research, choosing the right tissue format can be crucial to obtaining reliable and [...]
Published On: 04/09/2023
